16-OH-E1 % (Pre-menopausal)

Optimal Result: 15 - 50 %.

 

In a Hormone Metabolite Assessment Panel (HUMAP) for pre-menopausal women, the percentage of 16-Hydroxyestrone (16-OH-E1) is a critical marker for evaluating estrogen metabolism and its implications for health.

16-OH-E1 is a metabolite of estrogen, produced through the 16α-hydroxylation pathway, and is known for its strong estrogenic properties. In contrast to other estrogen metabolites that are less active, 16-OH-E1 has been linked to an increased risk of estrogen-sensitive conditions, such as certain types of breast and uterine cancers. It promotes the growth of estrogen-responsive tissues and can contribute to conditions associated with estrogen dominance. The percentage of 16-OH-E1 in a woman's hormonal profile is significant; a higher percentage can indicate an increased reliance on the 16α-hydroxylation pathway, potentially leading to an elevated risk for estrogen-related health issues. Factors that can influence the proportion of 16-OH-E1 include genetics, liver health, diet, lifestyle, and body composition, as obesity is known to affect estrogen metabolism. Thus, in a HUMAP panel, the 16-OH-E1 percentage is an important metric. It provides insights into the dominant pathways of estrogen metabolism in the body and helps in assessing the risk for conditions associated with high estrogenic activity. This understanding is crucial for guiding preventive and therapeutic strategies in managing hormonal health, especially in pre-menopausal women where hormonal balance is key to overall well-being.

What does it mean if your 16-OH-E1 % (Pre-menopausal) result is too low?

Low levels of 16-Hydroxyestrone (16-OH-E1) in a pre-menopausal woman, as assessed in a Hormone Metabolite Assessment Panel (HUMAP), can indicate certain aspects of estrogen metabolism and hormonal health. 16-OH-E1, produced through the 16α-hydroxylation pathway, is known for its potent estrogenic effects and has been linked to an increased risk of estrogen-sensitive conditions, like certain types of breast and uterine cancers. Therefore, lower levels of this metabolite generally suggest a reduced engagement in this pathway, potentially indicating a lower risk for conditions associated with high estrogenic activity. This could be a result of effective liver function, as the liver plays a significant role in hormone metabolism, or it might reflect dietary and lifestyle factors that favor less potent pathways of estrogen metabolism, such as the 2-hydroxylation pathway. Additionally, genetic factors might predispose an individual to metabolize estrogens differently, resulting in lower levels of 16-OH-E1. In the broader context of hormonal health, low levels of this metabolite, especially when coupled with a balanced overall estrogen metabolism profile, could be indicative of a favorable hormonal balance. This balance is important in pre-menopausal women not only for reducing the risk of estrogen-related disorders but also for maintaining overall reproductive health, bone density, and cardiovascular health. However, it's crucial to interpret these levels within the context of the entire hormonal panel and individual health factors, as hormonal health is multifaceted and influenced by a complex interplay of various factors.

What does it mean if your 16-OH-E1 % (Pre-menopausal) result is too high?

High levels of 16-Hydroxyestrone (16-OH-E1) in a pre-menopausal woman, as indicated in a Hormone Metabolite Assessment Panel (HUMAP), are significant as they point to an increased engagement in the 16α-hydroxylation pathway of estrogen metabolism. 16-OH-E1 is known for its potent estrogenic properties and has been associated with an elevated risk of estrogen-sensitive conditions, such as certain breast and uterine cancers.

Elevated levels suggest a higher production of this potent estrogen metabolite, which can lead to conditions related to estrogen dominance, characterized by symptoms like heavy menstrual bleeding, fibrocystic breasts, and mood swings. This metabolic tendency can be influenced by various factors, including genetics, obesity (as adipose tissue can contribute to estrogen production), liver function (which plays a crucial role in hormone metabolism), and lifestyle factors such as diet and physical activity. High levels of 16-OH-E1 might also impact the balance with other hormones, like progesterone, further complicating the hormonal milieu. Thus, in a pre-menopausal woman, high levels of 16-OH-E1 in a HUMAP panel necessitate a careful evaluation of estrogen metabolism and hormonal health. It underscores the need for potential interventions that might include dietary changes, lifestyle modifications, and possibly medical therapies to shift the balance of estrogen metabolism towards less potent pathways. Such interventions aim to mitigate the risks associated with high estrogenic activity and maintain overall hormonal balance and health.

10 000+ happy customers
100% satisfaction
★ ★ ★ ★ ★ customer support

Trust us to examine your lab results, guiding you towards improved health.

Use promo code to save 10% off any plan.


We implement proven measures to keep your data safe.

At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.